More on FATE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.97 |
|
|||
| Open | $1.97 | ||||
| 52 Wk High | $4.76 | ||||
| 52 Wk Low | $1.46 | ||||
| Day High | $1.97 | ||||
| Day Low | $1.97 | ||||
| P/E | N/A | ||||
| EPS | $-1.91 | ||||
| Volume | 1,364 | ||||
- Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
- Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
- H.C. Wainwright Reiterates Buy Rating on Fate Therapeutics (FATE)
- Form 8-K FATE THERAPEUTICS INC For: Jun 04
- Fate Therapeutics reports trial data on autoimmune treatments
- Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting
- Form 4 FATE THERAPEUTICS INC For: May 20 Filed by: TAHL CINDY
- Form 4 FATE THERAPEUTICS INC For: May 20 Filed by: Valamehr Bahram
Entities mentioned with FATE
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- S3 | View Related Stories »
- 13G | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
